NCT05656326

Brief Summary

The currently developed implementation study aims to evaluate if a patient-led home-based follow-up approach is successful, improves quality of life, reduces anxiety and lessens fear of cancer recurrence during the years after surgical treatment of colorectal cancer (CRC).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
41mo left

Started Aug 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Aug 2021Dec 2029

Study Start

First participant enrolled

August 23, 2021

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 2, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 19, 2022

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

September 25, 2024

Status Verified

September 1, 2024

Enrollment Period

8.3 years

First QC Date

December 2, 2022

Last Update Submit

September 23, 2024

Conditions

Keywords

Patient-ledHome-based

Outcome Measures

Primary Outcomes (1)

  • Successful implementation

    Patient-led follow-up will be considered successful if the used optional follow up rate is below 75%.

    Year 7 (after the last follow-up moment of the last included patient)

Secondary Outcomes (9)

  • Successful home-based sampling

    Year 7

  • Quality of life of cancer patients

    Year 7

  • Health-related quality of life

    Year 7

  • Momentary quality of life

    Year 7

  • Anxiety

    Year 7

  • +4 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are 18 years or older who received curative intent surgical treatment for CRC, and who (will) undergo postoperative surveillance are eligible. Patients can be included up to 6 months after surgery.

You may qualify if:

  • Histologically confirmed colorectal adenocarcinoma without distant metastasis and treated with curative intent surgical resection less than 6 months ago
  • Scheduled or currently undergoing postoperative surveillance according to national guidelines
  • Written informed consent by the patient

You may not qualify if:

  • Patients with a severely complicated postoperative course, needing in hospital follow-up longer than 6 months postoperatively
  • Patients enrolled in other studies that require strict adherence to any specific follow-up practice with regular imaging - yearly or more frequent - of the abdomen and/or thorax
  • Patients with comorbidity or other malignancy that requires imaging of the abdomen and/or thorax every year or more frequent
  • Inability to complete the questionnaires due to illiteracy and/or insufficient proficiency of the Dutch language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kelly Raquel Voigt

Rotterdam, South Holland, 3015 GD, Netherlands

Location

Related Publications (1)

  • Voigt KR, Wullaert L, Hoppener DJ, Schreinemakers JMJ, Doornebosch PG, Verseveld M, Peeters K, Verhoef C, Husson O, Grunhagen D. Patient-led home-based follow-up after surgery for colorectal cancer: the protocol of the prospective, multicentre FUTURE-primary implementation study. BMJ Open. 2023 Oct 12;13(10):e074089. doi: 10.1136/bmjopen-2023-074089.

Related Links

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Dirk J. Grünhagen, MD, PhD

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 2, 2022

First Posted

December 19, 2022

Study Start

August 23, 2021

Primary Completion (Estimated)

December 1, 2029

Study Completion (Estimated)

December 1, 2029

Last Updated

September 25, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations